Obtaining the NEAs Seal of Acceptance requires products to not only exclude certain known irritants and allergens (e.g., formaldehyde, shellac, citrus ingredients, etc.) but also meet specific clinical safety testing requirements.5 This means the product needs to be successfully tested for safety using human subjects
Pentadecapeptide BPC-157 enhances the growth hormone receptor expression in tendon fibroblasts
It is referred as the most critical antioxidant, shielding the body from the harmful effects of oxidants like cigarette smoke and alcohol consumption
The dose-response relationship was clear across the REDEFINE 2 trial's range of 0.3 mg to 4.5 mg weekly, with higher doses consistently producing greater weight reductions
Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Cini C, Butterfield DA (2006) In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 142-induced oxidative stress
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)